Status:
TERMINATED
Peanut Protein Supplementation to Prevent Muscle Atrophy and Improve Recovery Following Total Knee Arthroplasty
Lead Sponsor:
Auburn University
Collaborating Sponsors:
Edward Via College of Osteopathic Medicine-Auburn
Jack Hughston Memorial Hospital
Conditions:
Surgery
Eligibility:
All Genders
60-75 years
Phase:
NA
Brief Summary
This randomized controlled trial will study the effects of peanut protein supplementation on changes in muscle size and quality in patients undergoing total knee arthroplasty.
Detailed Description
Total knee arthroplasty (TKA) is an effective treatment for patients with knee osteoarthritis (OA) accompanied by severe pain and functional limitations. With the success of this treatment and increas...
Eligibility Criteria
Inclusion
- total knee arthroplasty scheduled within two weeks under the care of surgeons at the Jack Hughston Clinic
Exclusion
- history of invasive lower extremity surgery within the last 5 years
- allergy to peanuts or peanut products
- Body Mass Index \<20 or \>35 kg/m2
- currently adhering to a restrictive weight loss diet
- current or recent (within the last 2 months) steroid use
- any physical condition that interferes with performing post-surgery rehabilitation
- known peripheral vascular disease, kidney disease, liver disease, or uncontrolled endocrine disorder
- known overt cardiovascular or metabolic such as heart disease/failure or diabetes
- Radiation exposure within the last 6 months other than dental x-rays or associated with current knee treatment/diagnosis
Key Trial Info
Start Date :
August 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2022
Estimated Enrollment :
1 Patients enrolled
Trial Details
Trial ID
NCT04294563
Start Date
August 1 2021
End Date
April 1 2022
Last Update
April 21 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Auburn University
Auburn, Alabama, United States, 36849